# Catalent Belgium SA, Brussels-Capital Region, Belgium – FDA Inspections

Source: https://www.keypedia.com/companies/catalent-belgium-sa/f48653bf-84a2-4aeb-bdc3-ca2d0cc4fdf2

> Inspection records and compliance data for Catalent Belgium SA in Brussels-Capital Region. 14 FDA inspections on record, 6 Form 483s, last inspected July 12, 2024.

---

## Details

- Name: Catalent Belgium SA
- FEI Number: 3007647000
- Facility Type: Finished drug product manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: Font Saint-Landry 10
- Address Line 2: Brussels
- City: Brussels-Capital Region
- Country Name: Belgium
- Address: Font Saint-Landry 10 Brussels, Brussels-Capital Region, Belgium
- Country: Belgium

## Related Documents

- [483 - Catalent Belgium SA - Unknown Date](https://www.keypedia.com/records/483/catalent-belgium-sa/8c3c7fa7-4d02-435e-bfa7-eca8c01018fd) — source: FDA, date: Invalid Date
- [483 - Catalent Belgium SA - 2024-07-12](https://www.keypedia.com/records/483/catalent-belgium-sa/95dfaf1f-b957-49b3-84a4-d94cf642abc4) — source: FDA, date: July 12, 2024
- [FDA Inspection 1273463 - Catalent Belgium SA - 2024-07-12](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/b06edd4c-3645-4254-95ff-a6a49c912062) — source: FDA, date: July 12, 2024
- FDA Inspection 1246550 - Catalent Belgium SA - 2023-04-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 7, 2023
- [483 - Catalent Belgium SA - 2022-08-19](https://www.keypedia.com/records/483/catalent-belgium-sa/39127879-6006-4bf9-9097-c58baca0283e) — source: FDA, date: August 19, 2022
- [EIR - Catalent Belgium SA - 2022-08-19](https://www.keypedia.com/records/eir/catalent-belgium-sa/885f1132-6075-4922-909a-a5d88ab0e69d) — source: FDA, date: August 19, 2022
- [FDA Inspection 1177876 - Catalent Belgium SA - 2022-08-19](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/cda7d2d2-9318-4cf2-9c5a-332cc4e11987) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2022
- [483 - Catalent Belgium SA - 2021-10-26](https://www.keypedia.com/records/483/catalent-belgium-sa/5f428877-75e7-4d0c-a321-d784b42dae0b) — source: FDA, date: October 26, 2021
- [FDA Inspection 1136201 - Catalent Belgium SA - 2020-01-22](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/718d5f13-8833-4845-b87e-2fd3dce9c475) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2020
- [EIR - Catalent Belgium SA - 2019-06-19](https://www.keypedia.com/records/eir/catalent-belgium-sa/4209497b-8812-400c-846b-12e6f37f3784) — source: FDA, date: June 19, 2019
- [483 - Catalent Belgium SA - 2019-06-19](https://www.keypedia.com/records/483/catalent-belgium-sa/0bdc03da-0772-4c63-92a1-bf5a5e92ae50) — source: FDA, date: June 19, 2019
- [FDA Inspection 1093395 - Catalent Belgium SA - 2019-06-19](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/8808ef61-857f-4e6e-ad95-cd1aacefd7ff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2019
- [FDA Inspection 1082390 - Catalent Belgium SA - 2019-02-15](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/e06b9297-26d5-4f83-8a2e-a68bd54aee5c) — source: FDA, date: February 15, 2019
- [483 - Catalent Belgium SA - 2019-02-07](https://www.keypedia.com/records/483/catalent-belgium-sa/fa83cb21-e34f-4eac-9039-a029ee5ef976) — source: FDA, date: February 7, 2019
- [FDA Inspection 1061068 - Catalent Belgium SA - 2018-07-31](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/7d7ec872-9d8f-4a15-82c9-a72e04b548cf) — classification: No Action Indicated (NAI), source: FDA, date: July 31, 2018
- [483 - Catalent Belgium SA - 2017-07-07](https://www.keypedia.com/records/483/catalent-belgium-sa/53e42813-d6b8-477e-883e-6b1c94f2e69f) — source: FDA, date: July 7, 2017
- [FDA Inspection 1019956 - Catalent Belgium SA - 2017-07-07](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/05c3d94e-0d81-4422-ba2b-2c72ec462b3b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 7, 2017
- [483 - Catalent Belgium SA - 2016-11-25](https://www.keypedia.com/records/483/catalent-belgium-sa/1c9f4538-4467-45ac-b533-8f0bcb3d040a) — source: FDA, date: November 25, 2016
- [FDA Inspection 996402 - Catalent Belgium SA - 2016-11-25](https://www.keypedia.com/records/fda_inspections/catalent-belgium-sa/e68d342f-28b8-48c3-81ff-9c0e1951ee63) — classification: No Action Indicated (NAI), source: FDA, date: November 25, 2016
- FDA Inspection 996402 - Catalent Belgium SA - 2016-11-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 25, 2016

## Related Companies

- [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1)
- [Jubilant HollisterStier LLC](https://www.keypedia.com/companies/jubilant-hollisterstier-llc/2f8cb6dd-3555-4528-a2d6-d3b845d229ba)
- [Patheon Manufacturing Services LLC](https://www.keypedia.com/companies/patheon-manufacturing-services-llc/64087a9c-0f9c-44d7-aeb9-171f7bc13658)
- [CoreRX Inc.](https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa)
- [Hospira, Inc., A Pfizer Company](https://www.keypedia.com/companies/hospira-inc-a-pfizer-company/46d63c80-caf7-40db-8325-13fcade5e82c)
- [Pfizer Manufacturing Belgium NV](https://www.keypedia.com/companies/pfizer-manufacturing-belgium-nv/9251b625-0cd3-4c3e-8267-f0c88fe32d75)
- [Janssen Pharmaceuticals Inc.](https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623)
- [Afton Scientific, LLC](https://www.keypedia.com/companies/afton-scientific-llc/e5ec92fc-2eb5-4366-8d78-fd597c977fe8)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/947a0616-87f8-4886-a6c2-278c5e678192)
- [Steril-Gene Life Sciences Private Ltd](https://www.keypedia.com/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec)

## Related Officers

- [Compliance Officer](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)
- [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)
- [Jessica Hankins](https://www.keypedia.com/people/jessica-hankins/199a210e-6fa6-4d96-928d-4eee36658454)
- [FDA Biologics Investigator](https://www.keypedia.com/people/viviana-matta/6fecf0ca-0edc-4538-a57e-72642f41b5c7)